Protalix Biotherapeutics Inc. (PLX)
NYSE · Healthcare
Protalix Biotherapeutics Inc. Long Term Debt 2009–2025
Protalix Biotherapeutics Inc. annual long term debt history from 2011 to 2014. Long term debt refers to financial obligations that are due more than one year in the future.
- Protalix Biotherapeutics Inc. long term debt as of December 31, 2014: 912,000, a 61.54% decrease year-over-year.
- Protalix Biotherapeutics Inc. long term debt for 2014 were 912,000, a 61.54% decrease from 2013.
- Protalix Biotherapeutics Inc. long term debt for 2013 were 2.4M, a 56.29% decrease from 2012.
- Protalix Biotherapeutics Inc. long term debt for 2012 were 5.4M, a 17.38% decrease from 2011.
- Protalix Biotherapeutics Inc. long term debt for 2011 were 6.6M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Protalix Biotherapeutics Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2014 | $1 |
| 2013 | $2 |
| 2012 | $5 |
| 2011 | $7 |
Protalix Biotherapeutics Inc. Long Term Debt — FAQ
Protalix Biotherapeutics Inc. (PLX) long term debt over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PLX's long term debt history?
The chart and table above show Protalix Biotherapeutics Inc.'s long term debt by year and by quarter, including the growth rate.